Company to Present Lymphoma Vaccine

vaccine-closeup.jpg

A company has been working on a lymphoma vaccine that is waiting to go into trial:

"Biovest International, Inc. (OTCQB: BVTI) today announced that BiovaxID®, Biovest's personalized lymphoma vaccine, will be featured in an oral presentation at the American Society of Hematology (ASH) Annual Meeting on Monday, December 6th in Orlando, Florida.

Stephen J. Schuster, M.D., Associate Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, will deliver the BiovaxID presentation titled, “Vaccination with IgM but Not IgG Idiotype Prolongs Remission Duration in Follicular Lymphoma Patients.”"

Read More: http://www.drugs.com/clinical_trials/new-phase-iii-data-analysis-biovaxi...

LymphomaInfo Social